Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.27 USD | -5.72% | -5.72% | +12.13% |
05-14 | Aprea Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-02 | Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza as Chief Medical Officer | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.13% | 28.62M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- APRE Stock
- News Aprea Therapeutics, Inc.
- Transcript : Aprea Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 11